Point72 Hong Kong LTD Morphic Holding, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $62,377 - $93,636	2,806 New	2,806 $79,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $25,918 - $37,194	-715 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $28,082 - $42,652	649 Added 983.33%	715 $34,000
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $3,538 - $4,455	66 New	66 $4,000
Q4 2020 Feb 16, 2021	SELL	$25.66 - $34.55 $10,828 - $14,580	-422 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$22.51 - $30.11 $9,499 - $12,706	422 New	422 $12,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.